{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:43:02Z","timestamp":1793256182611,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T00:00:00Z","timestamp":1581897600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T00:00:00Z","timestamp":1581897600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","award":["UNICEF\/UNDP\/World Bank\/WHO Special Programme for Research and Training in Tropical Diseases"],"award-info":[{"award-number":["UNICEF\/UNDP\/World Bank\/WHO Special Programme for Research and Training in Tropical Diseases"]}],"id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","award":["FP7-281803 IDAMS"],"award-info":[{"award-number":["FP7-281803 IDAMS"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Dengue infection can cause a wide spectrum of clinical outcomes. The severe clinical manifestations occur sufficiently late in the disease course, during day 4\u20136 of illness, to allow a window of opportunity for risk stratification. Markers of inflammation may be useful biomarkers. We investigated the value of C-reactive protein (CRP) measured early on illness days 1\u20133 to predict dengue disease outcome and the difference in CRP levels between dengue and other febrile illnesses (OFI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>We performed a nested case-control study using the clinical data and samples collected from the IDAMS-consortium multi-country study. This was a prospective multi-center observational study that enrolled almost 8000 participants presenting with a dengue-like illness to outpatient facilities in 8 countries across Asia and Latin America. Predefined severity definitions of severe and intermediate dengue were used as the primary outcomes. A total of 281 cases with severe\/intermediate dengue were compared to 836 uncomplicated dengue patients as controls (ratio 1:3), and also 394 patients with OFI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In patients with confirmed dengue, median (interquartile range) of CRP level within the first 3 days was 30.2\u2009mg\/L (12.4\u201361.2\u2009mg\/L) (uncomplicated dengue, 28.6 (10.5\u201358.9); severe or intermediate dengue, 34.0 (17.4\u201371.8)). Higher CRP levels in the first 3 days of illness were associated with a higher risk of severe or intermediate outcome (OR 1.17, 95% CI 1.07\u20131.29), especially in children. Higher CRP levels, exceeding 30\u2009mg\/L, also associated with hospitalization (OR 1.37, 95% CI 1.14\u20131.64) and longer fever clearance time (HR 0.84, 95% CI 0.76\u20130.93), especially in adults. CRP levels in patients with dengue were higher than patients with potential viral infection but lower than patients with potential bacterial infection, resulting in a quadratic association between dengue diagnosis and CRP, with levels of approximately 30\u2009mg\/L associated with the highest risk of having dengue. CRP had a positive correlation with total white cell count and neutrophils and negative correlation with lymphocytes, but did not correlate with liver transaminases, albumin, or platelet nadir.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In summary, CRP measured in the first 3\u2009days of illness could be a useful biomarker for early dengue risk prediction and may assist differentiating dengue from other febrile illnesses.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12916-020-1496-1","type":"journal-article","created":{"date-parts":[[2020,2,16]],"date-time":"2020-02-16T19:02:42Z","timestamp":1581879762000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["C-reactive protein as a potential biomarker for disease progression in dengue: a multi-country observational study"],"prefix":"10.1186","volume":"18","author":[{"given":"Nguyen Lam","family":"Vuong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huynh Thi","family":"Le Duyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phung Khanh","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Thi Hoai","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Van","family":"Vinh Chau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen","family":"Van Kinh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngoun","family":"Chanpheaktra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy Chai See","family":"Lum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Pleit\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick Keith","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron Paul","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Rosenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Jaenisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Halleux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero Luigi","family":"Olliaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget","family":"Wills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2910-7819","authenticated-orcid":false,"given":"Sophie","family":"Yacoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,17]]},"reference":[{"issue":"15","key":"1496_CR1","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1056\/NEJMra1110265","volume":"366","author":"CP Simmons","year":"2012","unstructured":"Simmons CP, Farrar JJ, Nguyen V, Wills B. Dengue. N Engl J Med. 2012;366(15):1423\u201332.","journal-title":"N Engl J Med"},{"issue":"7446","key":"1496_CR2","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nature12060","volume":"496","author":"S Bhatt","year":"2013","unstructured":"Bhatt S, Gething PW, Brady OJ, et al. The global distribution and burden of dengue. Nature. 2013;496(7446):504\u20137.","journal-title":"Nature"},{"key":"1496_CR3","unstructured":"World Health Organization. Dengue: guidelines for treatment, prevention and control. New Edition. Geneva: World Health Organization; 2009."},{"key":"1496_CR4","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12916-014-0147-9","volume":"12","author":"S Yacoub","year":"2014","unstructured":"Yacoub S, Wills B. Predicting outcome from dengue. BMC Med. 2014;12:147.","journal-title":"BMC Med"},{"key":"1496_CR5","first-page":"936062","volume":"2015","author":"CC Chen","year":"2015","unstructured":"Chen CC, Lee IK, Liu JW, Huang SY, Wang L. Utility of C-reactive protein levels for early prediction of dengue severity in adults. Biomed Res Int. 2015;2015:936062.","journal-title":"Biomed Res Int"},{"issue":"1","key":"1496_CR6","first-page":"3","volume":"48","author":"S Eppy","year":"2016","unstructured":"Eppy S, Nainggolan L, Rumende CM. The differences between interleukin-6 and c-reactive protein levels among adult patients of dengue infection with and without plasma leakage. Acta Med Indones. 2016;48(1):3\u20139.","journal-title":"Acta Med Indones"},{"issue":"2","key":"1496_CR7","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/jmv.24341","volume":"88","author":"A Dur\u00e1n","year":"2016","unstructured":"Dur\u00e1n A, Gonz\u00e1lez A, Delgado L, Mosquera J, Valero N. Serum level of C-reactive protein is not a parameter to determine the difference between viral and atypical bacterial infections. J Med Virol. 2016;88(2):351\u20135.","journal-title":"J Med Virol"},{"issue":"7","key":"1496_CR8","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1089\/vim.2016.0026","volume":"29","author":"RN Feitosa","year":"2016","unstructured":"Feitosa RN, Vallinoto AC, Vasconcelos PF, et al. Gene polymorphisms and serum levels of pro- and anti-inflammatory markers in dengue viral infections. Viral Immunol. 2016;29(7):379\u201388.","journal-title":"Viral Immunol"},{"key":"1496_CR9","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12879-016-1440-3","volume":"16","author":"T Jaenisch","year":"2016","unstructured":"Jaenisch T, Tam DT, Kieu NT, et al. Clinical evaluation of dengue and identification of risk factors for severe disease: protocol for a multicentre study in 8 countries. BMC Infect Dis. 2016;16:120.","journal-title":"BMC Infect Dis"},{"issue":"10","key":"1496_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006497","volume":"12","author":"KM Tomashek","year":"2018","unstructured":"Tomashek KM, Wills B, See Lum LC, et al. Development of standard clinical endpoints for use in dengue interventional trials. PLoS Negl Trop Dis. 2018;12(10):e0006497.","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"1496_CR11","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/sim.4780080504","volume":"8","author":"S Durrleman","year":"1989","unstructured":"Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med. 1989 May;8(5):551\u201361.","journal-title":"Stat Med"},{"issue":"9","key":"1496_CR12","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.3390\/ijerph15092018","volume":"15","author":"Mohd Ahmad","year":"2018","unstructured":"Ahmad MH, Ibrahim MI, Mohamed Z, et al. The sensitivity, specificity and accuracy of warning signs in predicting severe dengue, the severe dengue prevalence and its associated factors. Int J Environ Res Public Health. 2018;15(9).","journal-title":"International Journal of Environmental Research and Public Health"},{"issue":"1","key":"1496_CR13","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12887-018-1078-y","volume":"18","author":"K Phakhounthong","year":"2018","unstructured":"Phakhounthong K, Chaovalit P, Jittamala P, et al. Predicting the severity of dengue fever in children on admission based on clinical features and laboratory indicators: application of classification tree analysis. BMC Pediatr. 2018;18(1):109.","journal-title":"BMC Pediatr"},{"issue":"8","key":"1496_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161696","volume":"11","author":"J Tamibmaniam","year":"2016","unstructured":"Tamibmaniam J, Hussin N, Cheah WK, Ng KS, Muninathan P. Proposal of a clinical decision tree algorithm using factors associated with severe dengue infection. PLoS One. 2016;11(8):e0161696.","journal-title":"PLoS One"},{"issue":"3","key":"1496_CR15","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.cell.2015.07.005","volume":"162","author":"MS Diamond","year":"2015","unstructured":"Diamond MS, Pierson TC. Molecular insight into dengue virus pathogenesis and its implications for disease control. Cell. 2015;162(3):488\u201392.","journal-title":"Cell"},{"issue":"8","key":"1496_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006782","volume":"4","author":"EJ Nascimento","year":"2009","unstructured":"Nascimento EJ, Silva AM, Cordeiro MT, et al. Alternative complement pathway deregulation is correlated with dengue severity. PLoS One. 2009;4(8):e6782.","journal-title":"PLoS One"},{"key":"1496_CR17","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ijid.2015.07.027","volume":"40","author":"AL Conroy","year":"2015","unstructured":"Conroy AL, G\u00e9lvez M, Hawkes M, et al. Host biomarkers are associated with progression to dengue haemorrhagic fever: a nested case-control study. Int J Infect Dis. 2015;40:45\u201353.","journal-title":"Int J Infect Dis"},{"issue":"1","key":"1496_CR18","doi-asserted-by":"publisher","first-page":"70","DOI":"10.4269\/ajtmh.2001.65.70","volume":"65","author":"M Juffrie","year":"2001","unstructured":"Juffrie M, Meer GM, Hack CE, et al. Inflammatory mediators in dengue virus infection in children: interleukin-6 and its relation to C-reactive protein and secretory phospholipase A2. Am J Trop Med Hyg. 2001;65(1):70\u20135.","journal-title":"Am J Trop Med Hyg"},{"issue":"12","key":"1496_CR19","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1172\/JCI200318921","volume":"111","author":"MB Pepys","year":"2003","unstructured":"Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003;111(12):1805\u201312.","journal-title":"J Clin Invest"},{"issue":"4","key":"1496_CR20","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/jmv.20397","volume":"76","author":"AT Mairuhu","year":"2005","unstructured":"Mairuhu AT, Peri G, Setiati TE, et al. Elevated plasma levels of the long pentraxin, pentraxin 3, in severe dengue virus infections. J Med Virol. 2005;76(4):547\u201352.","journal-title":"J Med Virol"},{"issue":"3","key":"1496_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007183","volume":"13","author":"S Prodjosoewojo","year":"2019","unstructured":"Prodjosoewojo S, Riswari SF, Djauhari H, et al. A novel diagnostic algorithm equipped on an automated hematology analyzer to differentiate between common causes of febrile illness in Southeast Asia. PLoS Negl Trop Dis. 2019;13(3):e0007183.","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"1496_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006477","volume":"12","author":"T Wangrangsimakul","year":"2018","unstructured":"Wangrangsimakul T, Althaus T, Mukaka M, et al. Causes of acute undifferentiated fever and the utility of biomarkers in Chiangrai, northern Thailand. PLoS Negl Trop Dis. 2018;12(5):e0006477.","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"1496_CR23","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.jmii.2016.08.018","volume":"51","author":"CH Chen","year":"2018","unstructured":"Chen CH, Huang YC, Kuo KC, Li CC. Clinical features and dynamic ordinary laboratory tests differentiating dengue fever from other febrile illnesses in children. J Microbiol Immunol Infect. 2018;51(5):614\u201320.","journal-title":"J Microbiol Immunol Infect"},{"issue":"3","key":"1496_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0152420","volume":"11","author":"Y Lubell","year":"2016","unstructured":"Lubell Y, Althaus T, Blacksell SD, et al. Modelling the impact and cost-effectiveness of biomarker tests as compared with pathogen-specific diagnostics in the management of undifferentiated fever in remote tropical settings. PLoS One. 2016;11(3):e0152420.","journal-title":"PLoS One"},{"issue":"1","key":"1496_CR25","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jmii.2014.12.001","volume":"50","author":"K Chang","year":"2017","unstructured":"Chang K, Lee NY, Ko WC, et al. Identification of factors for physicians to facilitate early differential diagnosis of scrub typhus, murine typhus, and Q fever from dengue fever in Taiwan. J Microbiol Immunol Infect. 2017;50(1):104\u201311.","journal-title":"J Microbiol Immunol Infect"},{"issue":"4","key":"1496_CR26","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/jtm.12122","volume":"21","author":"EC Cooper","year":"2014","unstructured":"Cooper EC, Ratnam I, Mohebbi M, Leder K. Laboratory features of common causes of fever in returned travelers. J Travel Med. 2014;21(4):235\u20139.","journal-title":"J Travel Med"},{"issue":"3","key":"1496_CR27","doi-asserted-by":"publisher","first-page":"444","DOI":"10.4269\/ajtmh.13-0536","volume":"90","author":"S Kutsuna","year":"2014","unstructured":"Kutsuna S, Hayakawa K, Kato Y, et al. The usefulness of serum C-reactive protein and total bilirubin levels for distinguishing between dengue fever and malaria in returned travelers. Am J Trop Med Hyg. 2014;90(3):444\u20138.","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"1496_CR28","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.jiac.2014.12.004","volume":"21","author":"Satoshi Kutsuna","year":"2015","unstructured":"Kutsuna S, Hayakawa K, Kato Y, et al. Comparison of clinical characteristics and laboratory findings of malaria, dengue, and enteric fever in returning travelers: 8-year experience at a referral center in Tokyo, Japan. Kansenshogaku Zasshi. 2015;21(4):272\u20136. https:\/\/doi.org\/10.1016\/j.jiac.2014.12.004.","journal-title":"Journal of Infection and Chemotherapy"},{"issue":"9","key":"1496_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002420","volume":"7","author":"L Epelboin","year":"2013","unstructured":"Epelboin L, Boull\u00e9 C, Ouar-Epelboin S, et al. Discriminating malaria from dengue fever in endemic areas: clinical and biological criteria, prognostic score and utility of the C-reactive protein: a retrospective matched-pair study in French Guiana. PLoS Negl Trop Dis. 2013;7(9):e2420.","journal-title":"PLoS Negl Trop Dis"},{"key":"1496_CR30","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/1423-0127-20-75","volume":"20","author":"TS Ho","year":"2013","unstructured":"Ho TS, Wang SM, Lin YS, Liu CC. Clinical and laboratory predictive markers for acute dengue infection. J Biomed Sci. 2013;20:75.","journal-title":"J Biomed Sci"},{"issue":"1","key":"1496_CR31","doi-asserted-by":"publisher","first-page":"e119","DOI":"10.1016\/S2214-109X(18)30444-3","volume":"7","author":"T Althaus","year":"2019","unstructured":"Althaus T, Greer RC, Swe MMM, et al. Effect of point-of-care C-reactive protein testing on antibiotic prescription in febrile patients attending primary care in Thailand and Myanmar: an open-label, randomised, controlled trial. Lancet Glob Health. 2019;7(1):e119\u2013e31.","journal-title":"Lancet Glob Health"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-020-1496-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12916-020-1496-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-020-1496-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T11:28:50Z","timestamp":1613561330000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-020-1496-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,17]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1496"],"URL":"https:\/\/doi.org\/10.1186\/s12916-020-1496-1","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.737390191.793571711","asserted-by":"object"}]},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,17]]},"assertion":[{"value":"8 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical Committee approval was obtained from Oxford Tropical Research Ethics Committee (OxTREC) in the UK, and from all the local IRBs at each site for the original observational study. Further minimal risk applications were obtained for use of stored samples from OxTREC, and all other participating hospitals from which residual samples were selected. All patients signed an informed consent form in the original study, which included permission for future use of stored blood samples.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SY receives consulting fees from Janssen pharmaceuticals for work on dengue antiviral development. All other authors declared that they have no competing interests. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest.CH is staff of the World Health Organization. The authors alone are responsible for the views expressed in this article, and they do not necessarily represent the views, decisions, or policies of the institutions with which they are affiliated.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35"}}